This session will cover the findings of the CTN-0097 SWIFT study, which demonstrated the effectiveness and safety of a rapid method of initiation of injection naltrexone among patients with opioid use disorder admitted to inpatient/residential treatment, using mainly non-opioid medications to combat withdrawal and low dose titration of oral naltrexone prior to naltrexone injection. This aims to make initiation of injection naltrexone more feasible within the time-frame of typical short term inpatient stays The session will also describe a shared decision making tool developed for SWIFT to guide discussion between clinicians and patients about choice of medication treatment for opioid use disorder, encouraging initiation of one of the effective medications to reduce risk of relapse and overdose.
Learning Objectives:
Learners will be able to:
Understand the findings of the CTN-0097 SWIFT study, including the principles and practice of shared decision making to help patients with opioid use disorder select a medication treatment, and clinical guidelines for rapid initiation of injection naltrexone.
